4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0000897069-25-001776
10% owner sold 21,295 shares at an average $10.93 ($232,690)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2025-12-04 | Sale | −5,000 | $9.06 | $45,300 | 177,654 | D |
| Cambrian BioPharma Inc 10% owner | 2025-12-05 | Sale | −14,508 | $11.40 | $165,391 | 163,146 | D |
| Cambrian BioPharma Inc 10% owner | 2025-12-05 | Sale | −1,745 | $12.29 | $21,446 | 161,401 | D |
| Cambrian BioPharma Inc 10% owner | 2025-12-05 | Sale | −42 | $13.16 | $553 | 161,359 | D |
| Open-market sales · 21,295 sh · avg $10.93 · $232,690 | |||||||
Loading xslF345X05/form4.xml…